Disease transmission model for community-associated Clostridium difficile infection

Epidemiology and Infection

Volumn 138, Issue 6, 2010, Pages 907-914

  Otten, A M ^a   Reid Smith, R J ^b   Fazil, A ^c   Weese, J S ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

Clostridium difficile; Infectious disease epidemiology; Transmission

Indexed keywords

CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY SAMPLE; DISEASE TRANSMISSION; FLUID INTAKE; FOOD INTAKE; HUMAN; NONHUMAN; REVIEW; RISK ASSESSMENT; RISK FACTOR; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CLOSTRIDIUM INFECTION; COMMUNICABLE DISEASE; DISEASE CARRIER;

ANIMALS; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE VECTORS; HUMANS; MODELS, BIOLOGICAL; RISK ASSESSMENT; RISK FACTORS;

EID: 77952498572     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991646     Document Type: Review

References (40)

1. Hall IC, O'Toole E. Intestinal flora in new-born infants with a description of a new pathogenic anaerobe. American Journal of Diseases of Children 1935; 49: 390-402.
2. Al Safi N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. Journal of Medical Microbiology 1996; 45: 133-137.
3. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clinical Infectious Diseases 1998; 26: 1027-1036.
4. Shim JK, et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998; 351: 633-636.
5. Norén T, et al. Molecular epidemiology of hospitalassociated and community-acquired Clostridium difficile infection in a Swedish county. Journal of Clinical Microbiology 2004; 42: 3635-3643.
6. Miller MA, et al. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infection Control and Hospital Epidemiology 2002; 23: 137-140.
7. Olson MM, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infection Control and Hospital Epidemiology 1994; 15: 371-381.
8. Bartlett JG, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New England Journal of Medicine 1978; 298: 531-534.
9. Hirschhorn LR, et al. Epidemiology of communityacquired Clostridium difficile-associated diarrhea. Journal of Infectious Diseases 1994; 169: 127-133.
10. Teasley DG, et al. Prospective randomised trial of Metronidazole versus Vancomycin for Clostridiumdifficile-associated diarrhoea and colitis. Lancet 1983; 322: 1043-1046.
11. Cohen SH, et al. Persistence of an endemic (toxigenic) isolate of Clostridium difficile in the environment of a general medicine ward. Clinical Infectious Diseases 2000; 30: 952-954.
12. Kim KH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibioticassociated colitis. Journal of Infectious Dieases 1981; 143: 42-50.
13. McFarland LV, et al. Nosocomial acquisition of Clostridium difficile infection. New England Journal of Medicine 1989; 320: 204-210.
14. Heard SR, et al. The epidemiology of Clostridium difficile with use of a typing scheme: Nosocomial acquisition and cross-infection among immunocompromised patients. Journal of Infectious Diseases 1986; 153: 159-162.
15. Chernak E, et al. Severe Clostridium difficile-associated disease in populations previously at low risk - four states, 2005. Morbidity and Mortality Weekly Report, December 2005 (http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5447a1.htm). Accessed 5 June 2007.
16. Pépin J, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Canadian Medical Association Journal 2004; 171: 466-472.
17. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. New England Journal of Medicine 1994; 330: 257-262.
18. O'Neill GL, Beaman MH, Riley TV. Relapse versus reinfection with Clostridium difficile. Epidemiology and Infection 1991; 107: 627-635.
19. Wilcox MH, et al. Recurrence of symptoms in Clostridium difficile infection - relapse or reinfection ? Journal of Hospital Infection 1998; 38: 93-100.
20. Johnson S, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with Vancomycin or Metronidazole. Annals of Internal Medicine 1992; 117: 297-302.
21. Rodriguez-Palacios A, et al. Clostridium difficile in retail ground meat, Canada. Emerging Infectious Diseases 2007; 13: 485-487.
22. Rodriguez-Palacios A, et al. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerging Infectious Diseases 2009; 5: 802-805 (http://www.cdc. gov/EID/content/15/5/802.htm).
23. Songer JG, et al. Clostridium difficile in retail meat products, US, 2007. Emerging Infectious Diseases 2009; 5: 819-821 (http://www.cdc.gov/EID/ content/1505/ 819.htm).
24. Fekety R, et al. Epidemiology of antibiotic-associated colitis. American Journal of Medicine 1981; 70: 906-908.
25. Clabots CR, et al. Acquisition of Clostridium difficile by hospitalized patients : evidence for colonized new admissions as a source of infection. Journal of Infectious Diseases 1992; 166: 561-567.
26. Fawley WN, Wilcox MH. Molecular epidemiology of endemic Clostridium difficile infection. Epidemiology and Infection 2001; 126: 343-350.
27. Mulligan ME, et al. Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis. American Journal of Clinical Nutrition 1980; 33: 2533-2538.
28. Ozaki E, et al. Clostridium difficile colonization in healthy adults : transient colonization and correlation with enterococcal colonization. Journal of Medical Microbiology 2004; 53: 167-172.
29. Perry C, Marshall R, Jones E. Bacterial contamination of uniforms. Journal of Hospital Infection 2001; 48: 238-241.
30. Stirling B, Littlejohn P, Willbond ML. Nurses and the control of infectious disease : Understanding epidemiology and disease transmission is vital to nursing care. Canadian Nurse 2004; 100: 16-20.
31. Bobulsky GS, et al. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clinical Infectious Diseases 2008; 46: 447-450.
32. Clooten J, et al. Prevalence and risk factors for Clostridium difficile colonization in dogs and cats hospitalized in an intensive care unit. Veterinary Microbiology 2008; 129: 209-214.
33. Matsuki S, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Internal Microbiology 2005; 8: 43-48.
34. Erdemoglu A, et al. Carriage of Clostridium difficile in dogs and cats. Indian Veterinary Journal 2005; 82: 929-932.
35. Struble AL, et al. Fecal shedding of Clostridium difficile in dogs: a period prevalence survey in a veterinary medical teaching hospital. Journal of Veterinary Diagnostic Investigation 1994; 6: 342-347.
36. Boriello SP, et al. Household pets as a potential reservoir for Clostridium difficile infection. Journal of Clinical Pathology 1983; 36: 84-87.
37. Riley TV, et al. Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiology and Infection 1991; 107: 659-665.
38. Arroyo LG, et al. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. Journal of Medical Microbiology 2005; 54: 163-166.
39. Lefebvre SL, Arroyo LG, Weese JS. Epidemic Clostridium difficile strain in hospital visitation dog. Emerging Infectious Diseases 2006; 12: 1036.
40. Rodriguez-Palacious A, et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerging Infectious Diseases 2006; 11: 1730-1736 (http://www.cdc.gov/ncidod/ EID/vol12no11/05-1581.htm).